Harvest Health & Recreation Inc. (“Harvest”) (CSE: HARV, OTCQX: HRVSF), a vertically integrated cannabis company and multi-state operator in the U.S., today announced the terms of select issued and outstanding warrants have been amended to reflect the exercise price of such warrants in U.S. dollars. The U.S. dollar exercise price was determined using the U.S. dollar exchange rate published by the Bank of Canada on the original date of issuance of each of the warrants.
The warrants were originally issued in May 2019 in connection with a private placement of convertible debt, December 2019 in connection with a private placement of senior secured debt, October 2020 in connection with a bought deal offering, and December 2020 in connection with a private transaction with an investor. To affect the conversion of the exercise price of the warrants to U.S. dollars, Harvest has entered into (1) supplemental warrant indentures dated June 30, 2021 with Odyssey Trust Company, a warrant agent, with respect to the warrants issued in December 2019 and October 2020 and (2) amendments to certificated warrants for the warrants issued in May 2019 and December 2020, each dated June 30, 2021.
The conversion of the exercise price of the warrants to U.S. dollars was driven by the accounting treatment of warrants denominated in a different currency than the functional currency of Harvest. Warrants with an exercise price denominated in Canadian dollars are classified as derivative liabilities at fair value in Harvest’s financial statements in accordance with U.S. GAAP. Harvest believes the impact of fluctuations in fair value on financial statements is not reflective of Harvest’s underlying performance. Following the conversion of the exercise price to U.S. dollars, the warrants will be classified as equity. Harvest believes this change will allow the financial statements to provide greater transparency into its operating performance. Harvest anticipates taking a charge in the three-month period ending June 30, 2021 for the period up and until the conversion of the exercise price of the warrants to U.S. Dollars.
